Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 475 to 524 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
238\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
asc-type amino acid transporter 1 (asc-1). [source:swissprot;acc:q9ns82]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6976.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7426.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06452\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 7; sds22. [source:refseq;acc:nm\_002712]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
27642.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
22440.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.23182\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
239\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase b precursor. [source:refseq;acc:nm\_020361]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7711.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6265.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.23071\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dna fragmentation factor 40 kda subunit (ec 3.-.-.-) (dff-40) (caspase-activated deoxyribonuclease) (caspase-activated dnase) (cad) (caspase-activated nuclease) (cpan). [source:swissprot;acc:o76075]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6456.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6872.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06449\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
240\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mast cell carboxypeptidase a precursor (ec 3.4.17.1) (mc-cpa) (carboxypeptidase a3). [source:swissprot;acc:p15088]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7711.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6265.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.23071\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d1 (snrnp core protein d1) (sm-d1) (sm-d autoantigen). [source:swissprot;acc:p13641]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7671.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8163.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06425\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
241\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glucosamine-6-phosphate isomerase. [source:refseq;acc:nm\_138335]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4585.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4311.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06356\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
plasma carboxypeptidase b2 isoform a preproprotein; carboxypeptidase u; thrombin-activatable fibrinolysis inhibitor; carboxypeptidase b-like protein; thrombin-activable fibrinolysis inhibitor. [source:refseq;acc:nm\_001872]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7711.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6265.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.23071\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
242\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glucosamine-6-phosphate isomerase (ec 3.5.99.6) (glucosamine-6- phosphate deaminase) (gnpda) (glcn6p deaminase) (oscillin). [source:swissprot;acc:p46926]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4585.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4311.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06356\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
max protein. [source:swissprot;acc:p25912]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4640.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5704.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22943\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
243\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 39 isoform 1; nuclear rna helicase, decd variant of dead box family. [source:refseq;acc:nm\_005804]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7648.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8133.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06338\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 2; homer homolog 3 (drosophila). [source:refseq;acc:nm\_004839]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4246.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5208.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22652\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
244\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 12b isoform a; myosin phosphatase regulatory subunit; myosin phosphatase, target subunit 2. [source:refseq;acc:nm\_002481]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8759.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9314.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06331\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquinone biosynthesis protein coq7 homolog (coenzyme q biosynthesis protein 7 homolog) (timing protein clk-1 homolog). [source:swissprot;acc:q99807]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4250.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5211.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22614\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
245\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 1b. [source:refseq;acc:nm\_004272]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4251.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5212.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22595\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tumor protein p73-like; tumor protein 63 kda with strong homology to p53; tumor protein p63. [source:refseq;acc:nm\_003722]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8509.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9047.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06313\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
246\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 3. [source:refseq;acc:nm\_004838]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4252.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5213.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22583\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tumor protein p73 (p53-like transcription factor) (p53-related protein). [source:swissprot;acc:o15350]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8509.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9046.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06312\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
247\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cellular tumor antigen p53 (tumor suppressor p53) (phosphoprotein p53) (antigen ny-co-13). [source:swissprot;acc:p04637]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8509.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9046.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0631\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein (wasp). [source:swissprot;acc:p42768]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6416.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7865.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22574\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
248\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene c-crk (p38) (adapter molecule crk). [source:swissprot;acc:p46108]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rabaptin, rab gtpase binding effector protein 1; rabaptin-5; neurocrescin. [source:refseq;acc:nm\_004703]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7615.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8095.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06302\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
249\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apg3p; pc3-96 protein. [source:refseq;acc:nm\_022488]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10547.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9924.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06276\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase abl2 (ec 2.7.1.112) (tyrosine kinase arg). [source:swissprot;acc:p42684]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
250\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
large neutral amino acids transporter small subunit 2 (l-type amino acid transporter 2) (hlat2). [source:swissprot;acc:q9uhi5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6975.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7412.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06261\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase src (ec 2.7.1.112) (p60-src) (c-src). [source:swissprot;acc:p12931]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
251\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
kynureninase (ec 3.7.1.3) (l-kynurenine hydrolase). [source:swissprot;acc:q16719]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8527.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9058.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06221\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase hck (ec 2.7.1.112) (p59-hck/p60-hck) (hemopoietic cell kinase). [source:swissprot;acc:p08631]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
252\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (ec 2.3.1.51) (1- agp acyltransferase 3) (1-agpat 3) (lysophosphatidic acid acyltransferase-gamma) (lpaat-gamma) (1-acylglycerol-3-phosphate o- acyltransferase 3). [source:swissprot;acc:q9nrz7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8492.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9018.94\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06194\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
crk-like protein. [source:swissprot;acc:p46109]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
253\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase isozyme 2 (ec 3.1.3.11) (d-fructose-1,6- bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:o00757]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8223.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8732.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06188\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase abl1 (ec 2.7.1.112) (p150) (c-abl). [source:swissprot;acc:p00519]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
254\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj842g6.2 (novel protein imilar to sel1l (sel-1 (suppressor of lin-12, c.elegans)-like)) (fragment). [source:sptrembl;acc:q9ugd3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8219.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8727.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06179\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fyn (ec 2.7.1.112) (p59-fyn) (syn) (slk). [source:swissprot;acc:p06241]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
255\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fgr (ec 2.7.1.112) (p55-fgr) (c-fgr). [source:swissprot;acc:p09769]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sel-1 homolog precursor (suppressor of lin-12-like protein) (sel-1l). [source:swissprot;acc:q9ubv2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8219.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8727.84\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06179\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
256\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase (ec 3.1.3.11) (d-fructose-1,6-bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:p09467]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8216.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8723.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06171\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
grb2-related adaptor protein 2 (gads protein) (growth factor receptor binding protein) (grblg) (grf40 adaptor protein) (grf-40) (grb-2-like protein) (grb2l) (grbx) (p38) (hematopoietic cell-associated adaptor protein grpl) (adapter protein grid) (sh3-sh2-sh3 adaptor mona). [source:swissprot;acc:o75791]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22476\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
257\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat displacement protein (cdp) (cut-like 1). [source:swissprot;acc:p39880]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6417.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7858.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22452\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
synaptojanin 1 (ec 3.1.3.36) (synaptic inositol-1,4,5-trisphosphate 5- phosphatase 1). [source:swissprot;acc:o43426]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8082.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8579.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06157\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
258\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
aflatoxin b1 aldehyde reductase 2 (ec 1.-.-.-) (afb1-ar 2). [source:swissprot;acc:o95154]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
9249.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9818.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06154\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein cux-2 (cut-like 2) (fragment). [source:swissprot;acc:o14529]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7857.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22449\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
259\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neural wiskott-aldrich syndrome protein (n-wasp). [source:swissprot;acc:o00401]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6417.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22355\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
oligophrenin 1. [source:swissprot;acc:o60890]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6428.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6824.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06152\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
260\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
aflatoxin b1 aldehyde reductase 1 (ec 1.-.-.-) (afb1-ar 1) (aldoketoreductase 7). [source:swissprot;acc:o43488]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
9246.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9814.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06147\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal recognition particle 9 kda protein (srp9). [source:swissprot;acc:p49458]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4244.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5193.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22343\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
261\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adrenodoxin, mitochondrial precursor (adrenal ferredoxin) (hepatoredoxin) (ferredoxin 1). [source:swissprot;acc:p10109]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8837.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9379.17\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06133\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal recognition particle 9 kda protein (srp9). [source:swissprot;acc:p49458]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4247.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5192.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22255\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
262\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specific factor 4, 30kd subunit; cleavage-polyadenylation specificity factor, 30kd; no arches-like (zebrafish) zinc finger protein; cleavage-polyadenylation specificity factor. [source:refseq;acc:nm\_006693]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
24896.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
20431.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21852\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
oligophrenin-1 like protein (gtpase regulator associated with focal adhesion kinase). [source:swissprot;acc:q9una1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6440.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6834.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06122\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/